Cancer treatment company plans for public offeringJuly 25, 2019PetCure Oncology has engaged Boustead Securities for a Regulation D 506(c) offering.
SPONSORED CONTENTWhere unique needs meet innovative scienceFind precise, innovative solutions for your patients' unique needs + Learn More